Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Multifocal pyomyositis. Diagnosis on technetium-99m MDP bone scan.
Gallbladder visualization on a technetium-99m MDP bone scan.
Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate ((99m)Tc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms.
Higashiyama S, Yoshida A, Kawabe J.
Curr Med Imaging. 2021;17(1):89-96. doi: 10.2174/1573405616666200528153453.
Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
J Nucl Med. 1985 Oct;26(10):1135-9.
Prospective Comparison of the Imaging Value of 99m Tc-MDP Bone Scan and 68 Ga-FAPI-04 PET/CT in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
Xu T, Ding H, Fan D, Shu Q, Liu G, Zhang S, Chen Y.
Clin Nucl Med. 2023 Sep 1;48(9):768-774. doi: 10.1097/RLU.0000000000004752. Epub 2023 Jun 23.
Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY, Papoff W.
Clin Nucl Med. 1987 Jan;12(1):45-6.
Technetium-99m MDP bone scintigraphy shows multiple abnormalities in sickle cell disease.
Adams BK, Parkar S, Al-Haider ZY.
Arch Dis Child. 2003 Jul;88(7):631. doi: 10.1136/adc.88.7.631.
Localization of technetium-99m methylene diphosphonate in bone using microautoradiography.
Einhorn TA, Vigorita VJ, Aaron A.
J Orthop Res. 1986;4(2):180-7. doi: 10.1002/jor.1100040206.
A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99m Tc-MDP Scintigraphy.
Araki Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Higuchi T, Abe K, Taniguchi Y, Yonezawa H, Morinaga S, Asano Y, Nojima T, Taki J, Tsuchiya H.
Clin Nucl Med. 2023 Jan 1;48(1):25-34. doi: 10.1097/RLU.0000000000004436. Epub 2022 Oct 14.
Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Basoglu T, Canbaz F, Bernay I.
J Nucl Med. 1998 Dec;39(12):2034, 5A.
Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH, Chung JK, Choi CW, Jeong JM, Lee DS, Bang YJ, Lee MC, Kim NK, Koh CS.
J Nucl Med. 1995 Oct;36(10):1800-5.
Quantitative (99m)Tc-MDP SPECT/CT as an alternative to (18)F-NaF PET/CT for objective assessment of osteoblastic bone metastases.
Coskun N, Cagdas B, Yildirim N.
Hell J Nucl Med. 2022 May-Aug;25(2):132-137. doi: 10.1967/s002449912472. Epub 2022 Aug 3.
